Mycobacterium africanum: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tag: Reverted |
||
| Line 28: | Line 28: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 20:21, 17 March 2025
Mycobacterium africanum is a type of bacteria that is part of the Mycobacterium tuberculosis complex (MTBC). It is one of the causative agents of tuberculosis (TB) in humans, particularly in West Africa.
History
Mycobacterium africanum was first described in 1968 by a French scientist named Castets. It was isolated from the sputum of a Senegalese patient who had pulmonary tuberculosis. The bacterium was named "africanum" due to its prevalence in Africa.
Characteristics
Mycobacterium africanum is a slow-growing, acid-fast bacterium. It shares many characteristics with other members of the MTBC, including Mycobacterium tuberculosis and Mycobacterium bovis. However, it has some unique genetic and phenotypic characteristics that distinguish it from other MTBC members.
Epidemiology
Mycobacterium africanum is responsible for a significant proportion of TB cases in West Africa. It is less common in other parts of the world. The reasons for this geographical restriction are not fully understood, but it is thought to be related to both host and bacterial factors.
Clinical significance
Infection with Mycobacterium africanum can lead to the development of TB. The clinical presentation and treatment of TB caused by Mycobacterium africanum is similar to that of TB caused by Mycobacterium tuberculosis. However, some studies suggest that Mycobacterium africanum may be associated with a slower disease progression and a lower transmission rate than Mycobacterium tuberculosis.
Research
Research on Mycobacterium africanum is ongoing to better understand its biology, epidemiology, and pathogenesis. This research is important for the development of new strategies for the prevention and treatment of TB.
